Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Capital Employed (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Return on Capital Employed for 14 consecutive years, with 0.43% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 1.0% to 0.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.43% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.45% for FY2025, 1.0% down from the prior year.
  • Return on Capital Employed hit 0.43% in Q4 2025 for Guided Therapeutics, up from 0.4% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 4.27% in Q1 2023 to a low of 0.22% in Q1 2021.
  • Historically, Return on Capital Employed has averaged 0.98% across 5 years, with a median of 0.55% in 2022.
  • Biggest five-year swings in Return on Capital Employed: skyrocketed 369bps in 2023 and later plummeted -348bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.61% in 2021, then soared by 339bps to 2.66% in 2022, then plummeted by -57bps to 1.14% in 2023, then tumbled by -62bps to 0.44% in 2024, then decreased by -1bps to 0.43% in 2025.
  • Business Quant data shows Return on Capital Employed for GTHP at 0.43% in Q4 2025, 0.4% in Q3 2025, and 0.42% in Q2 2025.